References
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. 4th edition, Text revision. Washington, DC: American Psychiatric Association
- Arendt J. (2005). Melatonin: Characteristics, concerns, and prospects. J Biol Rhythms. 20:291–303
- Axelrod J. (1974). Pineal-gland – A neurochemical transducer. Science. 184:1341–8
- Beck AT, Erbaugh J, Ward CH, et al. (1961). An inventory for measuring depression. Arch Gen Psychiatry. 4:561–71
- Box GEP, Jenkins GM. (1976). Time-series analysis: Forecasting and control (rev. ed.). San Francisco, CA: Holden-Day
- Brzezinski A, Lynch HJ, Seibel MM, et al. (1988). The circadian-rhythm of plasma melatonin during the normal menstrual-cycle and in amenorrheic women. J Clin Endocrinol Metab. 66:891–5
- Bubenik GA, Konturek SJ. (2011). Melatonin and aging: Prospects for human treatment. J Physiol Pharmacol. 62:13–19
- Cardinali DP, Srinivasan V, Brzezinski A, Brown GM. (2012). Melatonin and its analogs in insomnia and depression. J Pineal Res. 52:365–75
- Dallaspezia S, Benedetti F. (2011). Chronobiological therapy for mood disorders. Exp Rev Neurotherap. 11:961–70
- de Jong WHA, De Vries EGE, Kema IP. (2011). Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines. Clin Biochem. 44:95–103
- Hamaker EL. (2012). Why researchers should think “within-person”: a paradigmatic rationale. In Mehl M, Conner TS, eds. Handbook of research methods for studying daily life. New York, NY: The Guilford Press, pp. 43–61
- Hickie IB, Rogers NL. (2011). Novel melatonin-based therapies: Potential advances in the treatment of major depression. Lancet. 378:621–31
- Jahng S, Wood PK, Trull TJ. (2008). Analysis of affective instability in ecological momentary assessment: Indices using successive difference and group comparison via multilevel modeling. Psychol Methods. 13:354–75
- Lanfumey L, Mongeau R, Hamon M. (2013). Biological rhythms and melatonin in mood disorders and their treatments. Pharmacol Ther. 138:176–84
- McClung CA. (2007). Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. 114:222–32
- Molenaar PCM, Campbell CG. (2009). The new person-specific paradigm in psychology. Curr Dir Psychol Sci. 18:112–17
- Peuhkuri K, Sihvola N, Korpela R. (2012). Dietary factors and fluctuating levels of melatonin. Food Nutri Res. 56:17252
- Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
- Reiter RJ. (1993). The melatonin rhythm: Both a clock and a calendar. Experientia. 49:654–64
- Roenneberg T, Kuehnle T, Juda M, et al. (2007). Epidemiology of the human circadian clock. Sleep Med Rev. 11:429–38
- Srinivasan V, De Berardis D, Shillcutt SD, Brzezinski A. (2012). Role of melatonin in mood disorders and the antidepressant effects of agomelatine. Expert Opin Investig Drugs. 21:1503–22
- Tan DX, Manchester LC, Hardeland R, et al. (2003). Melatonin: A hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res. 34:75–8
- Van Faassen M, Booij SH, Bouwmans MEJ, et al. (2014). Automated mass spectrometric quantification of cortisol and melatonin in saliva. (Submitted for publication)
- Wetterberg L. (1998). Melatonin in adult depression. In Shafii M, Shafii SL, eds. Melatonin in psychiatric and neoplastic disorders. Washington, DC: American Psychiatry Press, pp. 43–79
- Wulff K, Joyce E, Middleton B, et al. (2006). The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: A case report. Chronobiol Int. 23:485–95